ASX - By Stock
|
EYE |
Re:
The Bear Room
|
|
Tekvest
|
287 |
49K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
287
|
49K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
EYE Summary (August 2024): Incredibly Undervalued
|
|
Tekvest
|
376 |
68K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
376
|
68K
|
0
|
|
ASX - By Stock
|
SPT |
Re:
The Next Chapter
|
|
Tekvest
|
5.1K |
1.4M |
3 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
5.1K
|
1.4M
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
3 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
The Bear Room
|
|
Tekvest
|
3.2K |
702K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
3.2K
|
702K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
The Bear Room
|
|
Tekvest
|
3.2K |
702K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
3.2K
|
702K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
The Bear Room
|
|
Tekvest
|
3.2K |
702K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
3.2K
|
702K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: ZIP Share Purchase Plan
|
|
Tekvest
|
119 |
39K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
119
|
39K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: ZIP Share Purchase Plan
|
|
Tekvest
|
119 |
39K |
3 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
119
|
39K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: ZIP Share Purchase Plan
|
|
Tekvest
|
119 |
39K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
119
|
39K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: ZIP Share Purchase Plan
|
|
Tekvest
|
119 |
39K |
3 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
119
|
39K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: ZIP Share Purchase Plan
|
|
Tekvest
|
119 |
39K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
119
|
39K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: ZIP Share Purchase Plan
|
|
Tekvest
|
119 |
39K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
119
|
39K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
EYE Summary (August 2024): Incredibly Undervalued
|
|
Tekvest
|
376 |
68K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
376
|
68K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Biosimilar Update
|
|
Tekvest
|
11 |
3.2K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
11
|
3.2K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
The Bear Room
|
|
Tekvest
|
3.2K |
702K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
3.2K
|
702K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
The Bear Room
|
|
Tekvest
|
3.2K |
702K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
3.2K
|
702K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Biosimilar Update
|
|
Tekvest
|
11 |
3.2K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
11
|
3.2K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
The Bear Room
|
|
Tekvest
|
3.2K |
702K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
3.2K
|
702K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
Tekvest
|
507 |
113K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
507
|
113K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Zip FY24 Results - Conference Call Details
|
|
Tekvest
|
6 |
2.6K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
6
|
2.6K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
Tekvest
|
507 |
113K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
507
|
113K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
Tekvest
|
507 |
113K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
507
|
113K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
Tekvest
|
507 |
113K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
507
|
113K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Zip FY24 Results - Conference Call Details
|
|
Tekvest
|
6 |
2.6K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
6
|
2.6K
|
2
|
|
ASX - By Stock
|
SPT |
Re:
The Next Chapter
|
|
Tekvest
|
5.1K |
1.4M |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
5.1K
|
1.4M
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
Tekvest
|
507 |
113K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
507
|
113K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
Tekvest
|
507 |
113K |
0 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
507
|
113K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
EYE Summary (August 2024): Incredibly Undervalued
|
|
Tekvest
|
376 |
68K |
1 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
376
|
68K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
0 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
1 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
Tekvest
|
507 |
113K |
0 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
507
|
113K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
0 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
0
|
|
ASX - By Stock
|
MME |
Re:
Ann: 4Q24 Trading Update - Growth and strong loan performance
|
|
Tekvest
|
133 |
36K |
0 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
133
|
36K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
Tekvest
|
507 |
113K |
1 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
507
|
113K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
Tekvest
|
2.1K |
526K |
0 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
2.1K
|
526K
|
0
|
|
ASX - By Stock
|
MME |
Re:
Ann: 4Q24 Trading Update - Growth and strong loan performance
|
|
Tekvest
|
133 |
36K |
0 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
133
|
36K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
EYE Summary (August 2024): Incredibly Undervalued
|
|
Tekvest
|
376 |
68K |
3 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
376
|
68K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
Tekvest
|
507 |
113K |
3 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
507
|
113K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
#BnplGoingToZero
|
|
Tekvest
|
922 |
260K |
1 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
922
|
260K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
So what is Fair Value of 'EYE'?
|
|
Tekvest
|
16 |
3.7K |
3 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
16
|
3.7K
|
3
|
|